Disease Overview：Unexplained infertility（UI）
Unexplained infertility refers to the inability to achieve clinical pregnancy after 12 months of regular, unprotected intercourse—despite comprehensive evaluation revealing no identifiable cause in either partner. Diagnostic workup typically includes semen analysis, ovarian reserve assessment (AMH, AFC), tubal patency testing (hysterosalpingography or sonohysterography), ovulation confirmation, and uterine cavity evaluation (hysteroscopy). When all standard investigations—including karyotyping, thrombophilia screening, and endometrial receptivity testing in select cases—return normal results, the diagnosis is confirmed. Prevalence ranges from 10–30% among infertile couples, reflecting limitations in current diagnostic sensitivity rather than absence of pathology. Management often begins with timed intercourse or intrauterine insemination (IUI), progressing to assisted reproductive technologies (ART) such as IVF/ICSI, sometimes incorporating adjunctive strategies like preimplantation genetic testing for aneuploidy (PGT-A), endometrial scratching, or immunomodulatory protocols based on emerging evidence.
China offers distinct advantages for international patients seeking care for unexplained infertility. The country hosts nationally accredited Reproductive Medicine Centers with board-certified reproductive endocrinologists and embryologists trained in advanced ART protocols—including time-lapse embryo imaging, vitrification, and personalized ovarian stimulation regimens. Many centers report live birth rates per fresh IVF cycle exceeding 55% for women under 35, supported by state-of-the-art laboratories meeting ISO 15189 standards. Treatment costs are typically 40–60% lower than in the US, UK, or Australia—without compromising clinical rigor or laboratory quality. As a dedicated medical tourism agency, we facilitate seamless access to these high-performing centers: coordinating consultations, verifying physician credentials, securing priority scheduling, providing itemized, transparent pricing in advance, and delivering end-to-end support—from visa assistance and accommodation to bilingual nursing liaison and post-treatment follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Unexplained Infertility (Reproductive Medicine Department)
Non-Surgical / Conservative / Medication Options
*Target criteria:* Couples with normal semen analysis, patent fallopian tubes (confirmed by HSG), regular ovulation, and no uterine cavity abnormalities.
- •Ovulation Monitoring + Timed Intercourse (3 cycles)
- Mid-cycle transvaginal ultrasound (×3, $65 each → $195) - Serum E2/P4/LH testing (×3 cycles, $30/test → $90) *Total: $330*
- •Clomiphene Citrate or Letrozole Ovulation Induction (3 cycles)
- Monitoring ultrasounds (×3–4/cycle, $65 each → $780 total) - Serum progesterone day-21 test (×3, $30 → $90) *Total: $895*
- •Gonadotropin-Based OI (3 cycles)
- Ultrasound monitoring (×5–6/cycle → $975 total) - Serum E2 (×3/cycle → $270), P4 (×3/cycle → $90) *Total: $1,455*
Surgical / Procedural / Interventional Options
*Eligibility:* Confirmed unexplained infertility after ≥2 years; failed ≥3 cycles of ovulation induction; no contraindications to anesthesia.
- •Diagnostic Laparoscopy + Chromopertubation
- Procedure (including anesthesia, OR fee, dye test): $1,850–$2,300 - Histopathology (if endometriosis suspected): $110 *Total range: $2,150–$2,595*
- •Intrauterine Insemination (IUI) — 3 cycles
- Transvaginal ultrasound monitoring (×2–3/cycle → $585 total) - Trigger injection (hCG, ×3): $45 *Total: $765*
- •In Vitro Fertilization (IVF-ET) — 1 fresh cycle
- Ovarian stimulation drugs (recombinant FSH/LH + GnRH antagonist): $780 - Egg retrieval + embryo culture + fresh ET: $4,200 - Embryo freezing (if needed): $220 *Total (fresh cycle): $5,520*
Special/Complex Condition Options
- •Endometrial Receptivity Analysis (ERA): $890
- •Preimplantation Genetic Testing for Aneuploidy (PGT-A): $1,650 (added to IVF cycle)
- •Immunomodulation (IVIG or intralipid infusion): $1,100–$1,450 per course (evidence-limited; reserved for recurrent implantation failure)
Quick Selection Guide
- •Age <35, budget <$1,000, no comorbidities: Start with ovulation monitoring + timed intercourse ($330), then progress to letrozole OI ($895).
- •Age 35–37, moderate budget ($2,500–$5,500): Proceed directly to IUI ×3 ($765); if unsuccessful, advance to IVF ($5,520).
- •Age ≥38 or prior failed OI/IUI: Skip to IVF ($5,520); add PGT-A ($1,650) if ≥2 prior miscarriages or repeated implantation failure.
- •Suspected subtle endometriosis or adhesions: Diagnostic laparoscopy ($2,150–$2,595) before IVF—especially if pelvic pain or elevated CA-125.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Unexplained infertility Medical Vacation Packages
Curated transparent all-inclusive packages combining Unexplained infertility treatment with China top medical destinations:
